Note: In keeping with the Agile Cincinnati mission, to provide Lean/Agile topics for all areas of the organization, July’s topic will focus on lean principles applied outside of software development.
Abstract:
Connectedness of global markets, constrained healthcare resources, aging populations, chronic diseases, and the economics of healthcare puts healthcare systems in a crisis of affordability. But who pays?
For a medtech company the market grows more complex. Incremental innovation (making a better product) at higher prices will not sustain in the current market. The medtech industry will see pressures like never before. New consumers and patients are participating in healthcare choices and decisions like never before. The non-clinical stakeholders like payers and materials managers, even the C-suite of the hospital are driving price transparency and economic pressures onto industry. The healthcare stakeholders are shifting the acceptable levels of risk (legal, financial, clinical) and evidence-based medicine is driving market adoption dynamics. Comparative effectiveness studies, solutions beyond the medical job, growth of HTA’s, and longer regulatory approval times & increased hurdles contribute to the increased complexity. The capability to accelerate speed to key data is critical.
The paradox is that innovative technology can change healthcare delivery and put an end to the crisis. Basic research breakthroughs are plentiful and innovation is necessary for business vitality. New technology will drive above average growth in this market but buying the technology is expensive. As L&A targets are increasing in cost, companies will turn to organic growth.
How will companies speed to data and technology innovation to reduce risks for patients, physicians, providers, and payers while complying with regulatory requirements and the pressures on their own business to be profitable and lean?
Bio:
Teresa serves as Director of Strategy Execution reporting to the Company Group Chairman of the Board for Ethicon Endo-Surgery, Inc. (a Johnson & Johnson company) in Cincinnati, OH. In this position, Teresa is responsible for creating integrated business processes and programs to enable new strategic capabilities targeted at realization of the long term strategic plan of the company.
In Teresa’s prior position(s) she worked in the front-end pipeline processes with key physicians and inventors to bring first to market innovations from concept to clinical. As Director of Quality Systems, Regulatory Affairs, and Short Run Manufacturing, she designed and implemented a risk-based quality system for outsourcing medical design and manufacture.
Prior to joining Johnson & Johnson in March 2001, Teresa held various positions for Global Compliance at Bausch & Lomb, Inc. and for Quality Systems and Regulatory Affairs at Mallinckrodt, Inc. Teresa has more than 20 years of experience in the medical device industry in quality, regulatory, compliance, and clinical affairs over multiple specialty areas spanning global operations, new product development, and worldwide commercial enterprise.
Teresa holds a bachelor’s degree in biology and applied mathematics from Washington University in St. Louis, MO.
When: July 14 (Second Thursday of July). Networking and dinner: 5:30-6pm. Program: 6-7:30pm.
Where: Max Training. 4900 Parkway Drive Suite 160 , Mason (Cincinnati), OH 45040
Food sponsor: Seapine Software. Thank you!
This event qualifies for 1 PDU. Attendees must pre-register through Eventbrite and sign in at the door to qualify.